We are live on ! Find out more
FMWA

Forvis Mazars Wealth Advisors Portfolio holdings

AUM $5.27B
1-Year Est. Return 18.06%
This Fund
S&P 500
This Quarter Est. Return
-1.66%
1 Year Est. Return
+18.06%
3 Year Est. Return
+51.15%
5 Year Est. Return
+52.01%
10 Year Est. Return
+190.2%
AUM
$4.17B
AUM Growth
-$169M
Cap. Flow
-$82.9M
Cap. Flow %
-1.99%
Top 10 Hldgs %
59.13%
Holding
434
New
14
Increased
132
Reduced
214
Closed
45

Sector Composition

Rank Sector Weight
1 Technology 4.72%
2 Healthcare 2.34%
3 Financials 1.92%
4 Consumer Discretionary 1.5%
5 Industrials 1.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRO icon
426
Sutro Biopharma
STRO
$416M
-1,284
Closed -$23.6K
TRI icon
427
Thomson Reuters
TRI
$44.4B
-2,057
Closed -$335K
TRIN icon
428
Trinity Capital Inc.
TRIN
$1.6B
-26,664
Closed -$386K
VOOG icon
429
Vanguard S&P 500 Growth ETF
VOOG
$26.4B
-40,626
Closed -$2.48M
VSS icon
430
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
-3,178
Closed -$364K
WTS icon
431
Watts Water Technologies
WTS
$11.7B
-1,600
Closed -$325K
SPLP
432
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
-8,051
Closed -$343K
CFB
433
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
-55,000
Closed -$833K
SILV
434
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
-11,000
Closed -$100K

Similar funds

Forvis Mazars Wealth Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Forvis Mazars Wealth Advisors held 434 positions worth $4.17B, down 3.9% from $4.34B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Forvis Mazars Wealth Advisors's Q1 2025 filing shows 14 new, 132 increased, 214 reduced and 45 closed positions. Its largest new stake was Vertex Pharmaceuticals: 1,448 shares worth $702K. The largest sale was iShares MSCI EAFE Small-Cap ETF, an estimated $17.1M.

By sector, the portfolio is most concentrated in Technology at 4.7% of assets, down from 5% a quarter earlier, followed by Healthcare and Financials.

  • Forvis Mazars Wealth Advisors's largest Q1 2025 buy was Vertex Pharmaceuticals: 1,448 shares worth $702K.
  • Forvis Mazars Wealth Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q1 2025, an estimated $66.6M increase.
  • Forvis Mazars Wealth Advisors's biggest Q1 2025 reduction was iShares MSCI EAFE Small-Cap ETF, cutting an estimated $17.1M.
  • Forvis Mazars Wealth Advisors fully exited Great Southern Bancorp in Q1 2025, selling an estimated $7.82M.
  • Forvis Mazars Wealth Advisors's ten largest holdings make up 59% of its $4.17B portfolio in Q1 2025.
  • Forvis Mazars Wealth Advisors opened 14 new positions and closed 45 in Q1 2025.
  • Forvis Mazars Wealth Advisors's portfolio value fell 3.9% quarter-over-quarter to $4.17B.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q1 2025, filed 13 May 2025.